Page last updated: 2024-08-24

2,4-diaminoquinazoline and Influenza, Human

2,4-diaminoquinazoline has been researched along with Influenza, Human in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
An, T; Han, SB; Jeong, EJ; Kim, H; Kim, M; Noh, K; Shin, JS	1

Other Studies

1 other study(ies) available for 2,4-diaminoquinazoline and Influenza, Human

Article	Year
The efficacy of a 2,4-diaminoquinazoline compound as an intranasal vaccine adjuvant to protect against influenza A virus infection in vivo. Journal of microbiology (Seoul, Korea), 2022, Volume: 60, Issue:5 Topics: Adjuvants, Immunologic; Adjuvants, Vaccine; Administration, Intranasal; Animals; Antibodies, Viral; Humans; Immunity, Mucosal; Influenza A virus; Influenza Vaccines; Influenza, Human; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Quinazolines; Toll-Like Receptor 7	2022

Article

Year

The efficacy of a 2,4-diaminoquinazoline compound as an intranasal vaccine adjuvant to protect against influenza A virus infection in vivo.

Journal of microbiology (Seoul, Korea), 2022, Volume: 60, Issue:5

Topics: Adjuvants, Immunologic; Adjuvants, Vaccine; Administration, Intranasal; Animals; Antibodies, Viral; Humans; Immunity, Mucosal; Influenza A virus; Influenza Vaccines; Influenza, Human; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Quinazolines; Toll-Like Receptor 7

2022